Evidence map›Paper›PMID 24037194›Full record

ArticleMemorias do Instituto Oswaldo Cruz2013

Antagonistic activity expressed by Shigella sonnei: identification of a putative new bacteriocin.

Mireille Ângela Bernardes Sousa, Luiz de Macêdo Farias, Patrícia Luciana de Oliveira, Jaqueline Silvana Moreira, Ana Carolina Morais Apolônio, Jamil Silvano Oliveira, Marcelo Matos Santoro, Edilberto Nogueira Mendes, Paula Prazeres Magalhães

Open access · diamondAbstract read
In one paragraph

Article in Memorias do Instituto Oswaldo Cruz, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Partial Characterization of Novel Bacteriocin SF1 Produced byInternational journal of microbiology · 2019
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Mireille Ângela Bernardes SousaDepartamento de Microbiologia, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo HorizonteMG, Brasil.
Luiz de Macêdo Farias
Patrícia Luciana de Oliveira
Jaqueline Silvana Moreira
Ana Carolina Morais Apolônio
Jamil Silvano Oliveira
Marcelo Matos Santoro
Edilberto Nogueira Mendes
Paula Prazeres Magalhães
Universidade Federal de Minas Gerais · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacteriocins are antibacterial, proteinaceous substances that mediate microbial dynamics. Bacteriocin production is a highly disseminated property among all major lineages of bacteria, including Shigella. In this paper, we addressed the purification and characterisation of a bacteriocin produced by a Shigella sonnei strain (SS9) isolated from a child with acute diarrhoea. The substance was purified through ammonium-sulphate precipitation and sequential steps of chromatography. The intracellular fraction obtained at 75% ammonium sulphate maintained activity following exposure to pH values from 1-11 and storage at -80ºC for more than two years and was inactivated by high temperatures and proteases. The molecular mass of the purified bacteriocin was determined by mass spectrometry to be 18.56 kDa. The N-terminal sequence of the bacteriocin did not match any other antibacterial proteins described. A putative new bacteriocin produced by S. sonnei has been detected. This bacteriocin may represent a newly described protein or a previously described protein with a newly detected function. Considering that SS9 expresses antagonism against other diarrhoeagenic bacteria, the bacteriocin may contribute to S. sonnei virulence and is potentially applicable to either preventing or controlling diarrhoeal disease.

Indexed as

Acute DiseaseAmino Acid SequenceBacteriocinsChromatography, Reverse-PhaseDiarrheaHumansMass SpectrometryShigella sonneiBacteriocins

Identifiers

PMID24037194
PMCPMC3970690
OpenAlexW2096775361

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.